Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127765051 | 12776505 | 1 | I | 201011 | 20160920 | 20160923 | 20160923 | EXP | NO-009507513-1609NOR011300 | MERCK | 73.00 | YR | M | Y | 0.00000 | 20160923 | CN | NO | NO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127765051 | 12776505 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, UNK | Y | 21995 | 100 | MG | FILM-COATED TABLET | ||||||
| 127765051 | 12776505 | 2 | C | AMARYL | GLIMEPIRIDE | 1 | 2 MG, UNK | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127765051 | 12776505 | 1 | Type 2 diabetes mellitus |
| 127765051 | 12776505 | 2 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127765051 | 12776505 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127765051 | 12776505 | Hypoglycaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127765051 | 12776505 | 1 | 201011 | 0 | ||
| 127765051 | 12776505 | 2 | 201011 | 0 |